Myelodysplastic Syndrome with Excess Blasts-2

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2 [Phase 3]

  A Phase III clinical trial is investigating induction and consolidation chemotherapy with venetoclax for newly diagnosed acute myeloid leuke…

• CLINICAL_TRIALS research · 2026-01-07
  Clinical Trial Update: Hu8F4 in Treating Patients With Advanced Hematologic Malignancies [Phase 1]

  Hu8F4 is being studied in a Phase 1 trial for multiple advanced hematologic malignancies; the study is currently active but not recruiting.

• CLINICAL_TRIALS research · 2025-08-26
  Clinical Trial Update: Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

  A phase 1/2 clinical trial is evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of Tuspetinib (HM43239) in patients…

• CLINICAL_TRIALS research · 2025-07-18
  Clinical Trial Update: BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 1]

  BXCL701 is being studied in a Phase 1 trial for relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome with excess blasts-2,…

• CLINICAL_TRIALS research · 2024-12-17
  Clinical Trial Update: A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy [Phase 3]

  Phase 3 clinical trial update comparing gilteritinib versus midostaurin in combination with induction, consolidation, and maintenance in adu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.